NCODA Logo

Oral Chemotherapy Induced Peripheral Neuropathy

Written by: Andrea Clarke, PharmD and Becky Fahrenbruch, PharmD, BCOP Download Here Description: Chemotherapy-induced peripheral neuropathy (CIPN) is a serious side effect that can occur with chemotherapeutics, including certain oral chemotherapy agents. Appropriate...

Olaparib (Lynparza®) Clinical Management

Written by: Katie Carter, PharmD, BCPS, Indiana University Health Download Here  Description: Olaparib is a poly ADP-ribose polymerase (PARP) enzyme inhibitor and is FDA approved as a targeted therapy for BRCA-mutated breast cancer, ovarian, pancreatic cancer, as well...